Search for: "In Re: Fosamax v." Results 81 - 100 of 109
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Dec 2011, 2:00 pm by Bexis
  In re Medtronic, Inc., Sprint Fidelis Leads Products Liability Litigation, 623 F.3d 1200, 1206 (8th Cir. 2010); Fosamax, 2011 WL 5903623, at *5; Wamsley v. [read post]
31 Aug 2010, 10:01 pm by Kelly
(FDA Law Blog) US: District Court N D Illinois construes claims re method of treating kidney disease: Bone Care v Pentech Pharma (Chicago IP Litigation Blog) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaint against Hospira in response to Para IV challenge (Patent Docs) Aranesp (Darbepoetin) – EU: ECJ to rule on Aranesp Thursday 2 Sept: Case C-66/09 Kirin Amgen (The SPC Blog) Baraclude (Entecavir) – India: Natco and Zydus… [read post]
12 Mar 2024, 12:46 pm by admin
Moye from giving such testimony); In re Rezulin Products Liab. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
24 Aug 2015, 5:00 am
McNeil Consumer Healthcare, 615 F.3d 861 (7th Cir. 2010); In re Fosamax, 951 F. [read post]
2 May 2019, 10:44 am by Schachtman
Litig., 858 F.3d 787 (3d Cir. 2017) (affirming MDL trial court’s Rule 702 exclusions of opinions that Zoloft is teratogenic); (5) Jones v. [read post]
19 May 2011, 1:15 pm
Essentially the same result occurred in In re Fosamax Products Liability Litigation, 645 F. [read post]
3 May 2011, 10:20 am by Bexis
App. 2003); In re Fosamax Products Liability Litigation, 742 F.Supp.2d 460, 471-72 (S.D.N.Y. 2010) (applying Florida law) (all refusing to apply §6(c) in cases involving prescription drugs).It's had somewhat more acceptance in device and vaccine cases where an alternative design requirement at least isn’t physically impossible. [read post]
14 Nov 2008, 10:46 pm
In other words, you’re going to, at the least, throw a monkey wrench into their year-end tax planning. [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC)   Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
1 Oct 2009, 2:14 am
While we're on the subject, can we get judges to rewrite the New Jersey and Minnesota statutes of limitations to add a borrowing statute? [read post]
23 May 2019, 9:30 pm by Alana Bevan
Court of Appeals for the Third Circuit, which held that a jury should determine if FDA would have added a warning to the labels of Merck osteoporosis drug Fosamax. [read post]
17 Oct 2015, 5:29 am by Schachtman
In re Paoli RR Yard PCB Litig., 35 F.3d 717, 745 (3d Cir. 1994). [read post]
17 Jan 2008, 10:00 pm
breaks new ground: (Rouse & Co International), Stopping China online content theft: (China Law Blog),Taking depositions in China: (Part 1 - Experience Not Logic), (Part 2 - Experience Not Logic), (Part 3 - Experience Not Logic).IP re-education a Sisyphean task: (China Hearsay),Patent challenge in China: What's the state of the art? [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]